Influenza IMPRINT Cohort: Defining the Impact of Initial Influenza Exposure on Immunity in Infants

Evaluation of Influenza-Specific Immune Responses in Children and Adults During the 2010-2011 Influenza Season in the U.S.

NCT01262079 ·Status: COMPLETED

Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intradermal Route)

NCT01138397 ·Status: COMPLETED ·Phase: PHASE3

Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunization With the H1N1 or Seasonal Influenza Vaccines

NCT01191853 ·Status: COMPLETED

Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old

NCT01992107 ·Status: COMPLETED ·Phase: PHASE3

Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months

NCT00996307 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Safety and Immunogenicity of a Four Influenza Vaccines in Children Ages 6 Months Old to Less Than 48 Months Old

NCT02035696 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

B-cell Immunity to Influenza (SLVP017)- Year 5, 2013

NCT03020537 ·Status: COMPLETED ·Phase: PHASE4

Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months

NCT00311428 ·Status: COMPLETED ·Phase: PHASE4

Immunogenicity and Safety of Inactivated H1N1 Swine-origin Influenza Monovalent Vaccine in Immunocompromised Children and Young Adults

NCT01000571 ·Status: COMPLETED

A Study to Describe Pediatric Influenza Vaccine Coverage

NCT00639418 ·Status: COMPLETED

The Impact of Imprinting and Repeated Influenza Vaccination on Adaptive Immunity, Transcriptomics, and Metabolomics

NCT03686514 ·Status: TERMINATED ·Phase: PHASE4

Revealing Protective Immunity to Influenza Using Systems Immunology

NCT06501963 ·Status: COMPLETED ·Phase: PHASE4

Influenza Vaccine in Pregnancy Part 2

NCT00593970 ·Status: COMPLETED

Effectiveness of Trivalent Inactivated Influenza Maternal Vaccination Among Pregnant Women and Their Newborns in South Africa

NCT02465190 ·Status: UNKNOWN

The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program

NCT05832307 ·Status: RECRUITING ·Phase: NA

Chart Review of Antivirals for Influenza in Infants

NCT00311701 ·Status: COMPLETED

Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children

NCT00391391 ·Status: COMPLETED ·Phase: PHASE2

Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011, in Healthy Subjects Aged Over 6 Months Old to 18 Years Old

NCT01356342 ·Status: COMPLETED ·Phase: PHASE4

Study of Immune Responses to Influenza Vaccination

NCT03346772 ·Status: RECRUITING ·Phase: PHASE4

Influenza Immunity in Children

NCT02559505 ·Status: COMPLETED ·Phase: NA

Immunogenicity, Safety and Tolerability of CSL Limited Inactivated Influenza Vaccine in Adults

NCT00333398 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Shedding and Safety of Trivalent Influenza Virus Vaccine Live, Intranasal in Infants and Young Children

NCT00344305 ·Status: COMPLETED ·Phase: PHASE2

Immune Response to Influenza Vaccination

NCT00551837 ·Status: COMPLETED

B-cell Immunity to Influenza (SLVP017)- Year 1, 2009

NCT02133781 ·Status: COMPLETED ·Phase: PHASE4

Flu Infection at UPHS

NCT06807840 ·Status: RECRUITING